Zihui Dong
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Performance and hypothetical clinical impact of an mNGS-based machine learning model for antimicrobial susceptibility prediction of five ESKAPEE bacteria.
Journal: Microbiology spectrum
Published: April 17, 2025
TM9SF1 inhibits colorectal cancer metastasis by targeting Vimentin for Tollip-mediated selective autophagic degradation.
Journal: Cell death and differentiation
Published: October 27, 2024
NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer.
Journal: Cell death discovery
Published: April 13, 2023
Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: February 24, 2023
Transcriptional analysis of the expression and prognostic value of lipid droplet-localized proteins in hepatocellular carcinoma.
Journal: BMC cancer
Published: January 06, 2023
Classification of Signature-Based Phenotypes of Aging-Related Genes to Identify Prognostic and Immune Characteristics in HCC.
Journal: Analytical cellular pathology (Amsterdam)
Published: September 14, 2022
The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer.
Journal: Frontiers in cell and developmental biology
Published: December 09, 2021
LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers.
Journal: Frontiers in cell and developmental biology
Published: September 29, 2021
PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration.
Journal: Journal of hepatocellular carcinoma
Published: September 03, 2021
Analysis of Multi-Layer RNA Modification Patterns for the Characterization of Tumor Immune Microenvironment in Hepatocellular Carcinoma.
Journal: Frontiers in cell and developmental biology
Published: August 19, 2021
Long Non-coding RNA Small Nucleolar RNA Host Gene 14, a Promising Biomarker and Therapeutic Target in Malignancy.
Journal: Frontiers in cell and developmental biology
Published: July 24, 2021
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 22, 2021
Last Updated: 09/26/2026